Skip to main content

Table 2 Lipid elements significantly elevated and declined alone in patients with pneumoconiosis as compared with healthy control (P-values)

From: Novel lipidomes profile and clinical phenotype identified in pneumoconiosis patients

Elevated > 1.5 fold

Declined < 2/threefold

Lipids

Fold

P-value

Lipids

Fold

P-value

PE(16:0/16:1)

2.68

0.00

PC(18:1/20:5)

0.67

0.03

PE(18:1/18:3)

2.65

0.00

LPC(20:0)

0.66

0.00

FFA(20:4)

2.46

0.03

TAG(58:7/FA18:0)

0.65

0.02

FFA(22:4)

2.43

0.00

PC(16:0/20:5)

0.64

0.03

TAG(55:4/FA18:2)

2.33

0.02

LPC(18:0)

0.63

0.00

PE(18:1/18:2)

2.19

0.00

TAG(58:9/FA18:1)

0.63

0.01

PE(18:1/18:1)

2.07

0.00

PC(14:0/22:6)

0.61

0.00

PE(16:0/18:3)

2.03

0.00

LPC(22:6)

0.61

0.00

PE(18:2/18:2)

2.02

0.00

PE(14:0/20:4)

0.61

0.00

FFA(20:5)

1.99

0.00

TAG(56:6/FA22:6)

0.59

0.05

PE(O-18:0/22:4)

1.97

0.03

PC(18:2/20:5)

0.57

0.00

PE(16:0/18:2)

1.90

0.00

TAG(56:7/FA16:0)

0.57

0.04

FFA(20:3)

1.88

0.01

CER(24:1)

0.56

0.00

PE(16:0/22:4)

1.83

0.01

TAG(58:7/FA16:0)

0.55

0.04

PE(16:0/18:1)

1.82

0.00

PC(20:0/22:6)

0.54

0.00

PE(18:2/20:2)

1.79

0.01

LPC(14:0)

0.54

0.00

PE(18:0/22:4)

1.73

0.04

TAG(55:1/FA16:0)

0.52

0.01

PE(18:0/16:1)

1.68

0.02

HCER(24:1)

0.49

0.00

PE(P-18:0/22:4)

1.63

0.00

PC(14:0/20:5)

0.48

0.02

TAG(55:4/FA18:1)

1.63

0.02

TAG(56:8/FA16:0)

0.47

0.02

PC(16:0/16:1)

1.61

0.01

LPC(20:5)

0.46

0.00

PE(18:0/16:0)

1.59

0.00

HCER(20:1)

0.45

0.00

PE(18:0/18:3)

1.56

0.02

PE(P-18:0/20:5)

0.44

0.01

PE(18:1/20:4)

1.55

0.00

PE(P-18:1/20:5)

0.40

0.02

PE(18:1/20:3)

1.51

0.01

PE(O-16:0/20:5)

0.39

0.01

PC(18:0/16:1)

1.50

0.02

PE(P-16:0/20:5)

0.36

0.03

   

DCER(22:0)

0.36

0.00

   

PC(20:0/20:5)

0.34

0.00

   

CER(22:1)

0.33

0.00

   

HCER(22:1)

0.32

0.00